臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"lin h w"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 141-165 / 342 (共14頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-02-06T05:22:07Z	Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways	WEN-FANG CHENG;Lin Chiang W.-H.;Lin H.-W.;Mao T.-L.;Chen Y.-L.;Chiang Y.-C.;Chen P.-J.;Chen C.-A.;Chang M.-C.; Chang M.-C.; Chen C.-A.; Chen P.-J.; Chiang Y.-C.; Chen Y.-L.; Mao T.-L.; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG; Chang M.-C.; Chen C.-A.; Chen P.-J.; Chiang Y.-C.; Chen Y.-L.; Mao T.-L.; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:22:07Z	Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response	WEN-FANG CHENG;Hsieh C.-Y.;Chen C.-A.;Lin H.-W.;Chiang Y.-C.;Huang C.-Y.;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; Huang C.-Y.; Chiang Y.-C.; Lin H.-W.; Chen C.-A.; Hsieh C.-Y.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C.; Huang C.-Y.; Chiang Y.-C.; Lin H.-W.; Chen C.-A.; Hsieh C.-Y.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:22:05Z	Depletion of Regulatory T Lymphocytes Reverses the Imbalance between Pro- and Anti-Tumor Immunities via Enhancing Antigen-Specific T Cell Immune Responses	Chien C.-L.;WEN-FANG CHENG;Lin H.-W.;Chen C.-A.;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; Chen C.-A.; Lin H.-W.; WEN-FANG CHENG; Chien C.-L.; Chien C.-L.; Chen Y.-L.; Chang M.-C.; Chen C.-A.; Lin H.-W.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:22:04Z	Interferon-gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma	WEN-FANG CHENG; Chang M.-C.; Lin H.-W.; Huang C.-T.; Chien C.-L.; Chen C.-A.; Chen C.-A.;Chien C.-L.;Huang C.-T.;Lin H.-W.;Chang M.-C.;WEN-FANG CHENG;Chen Y.-L.; Chen Y.-L.; WEN-FANG CHENG; Chang M.-C.; Lin H.-W.; Huang C.-T.; Chien C.-L.; Chen C.-A.; Chen Y.-L.
臺大學術典藏	2020-02-06T05:21:59Z	Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma	WEN-FANG CHENG;Chen C.-A.;Hsieh S.-F.;Chen T.-C.;Fu C.-F.;Chang M.-C.;Chang C.-F.;Lin H.-W.;Chiang Y.-C.; Chiang Y.-C.; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG; Chiang Y.-C.; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:58Z	IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients	WEN-FANG CHENG;Chen C.-A.;Hsieh S.-F.;Huang C.-T.;Lin H.-W.;Chang M.-C.;Chou C.-Y.;Chen Y.-L.; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:50Z	Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation	WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Sun N.-Y.;Lin H.-W.;Chiang Y.-C.;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:48Z	CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer	WEN-FANG CHENG;Chen C.-A.;Chiang Y.-C.;Lin H.-P.;Lu T.-P.;Chang M.-C.;Fu C.-F.;Lin H.-W.; Lin H.-W.; Fu C.-F.; Chang M.-C.; Lu T.-P.; Lin H.-P.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG; Lin H.-W.; Fu C.-F.; Chang M.-C.; Lu T.-P.; Lin H.-P.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:48Z	CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells	WEN-FANG CHENG;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chen Y.-L.;Sun N.-Y.;Chiang Y.-C.;Lin H.-W.; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:45Z	Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes	WEN-FANG CHENG;Chien C.-L.;Sun W.-Z.;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chiang Y.-C.;Lin H.-W.;Chen Y.-L.;Sun N.-Y.; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:43Z	mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment	WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Hung H.-C.;Yie J.-C.;Sun N.-Y.;Lin H.-W.;Chen Y.-L.; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏	2020-02-06T05:21:41Z	BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes	WEN-FANG CHENG; Chen C.-A.; Sun W.-Z.; Lai Y.-L.; Chien C.-L.; Lin H.-W.; Chen Y.-L.; WEN-FANG CHENG; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG;Chen C.-A.;Sun W.-Z.;Lai Y.-L.;Chien C.-L.;Lin H.-W.;Chen Y.-L.; Chen Y.-L.; Lin H.-W.; Chien C.-L.; Lai Y.-L.
臺大學術典藏	2020-01-22T07:50:43Z	Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways	Hsiao P.-N.; Chang M.-C.; Cheng W.-F.; CHI-AN CHEN; Lin H.-W.; Hsieh C.-Y.; Sun W.-Z.
臺大學術典藏	2020-01-22T07:50:39Z	Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response	Chen Y.-L.; Chang M.-C.; Huang C.-Y.; Chiang Y.-C.; Lin H.-W.; CHI-AN CHEN; Hsieh C.-Y.; Cheng W.-F.
臺大學術典藏	2020-01-22T07:50:38Z	Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways	Chang M.-C.; CHI-AN CHEN; Chen P.-J.; Chiang Y.-C.; Chen Y.-L.; Mao T.-L.; Lin H.-W.; Lin Chiang W.-H.; Cheng W.-F.
臺大學術典藏	2020-01-22T07:50:37Z	Depletion of Regulatory T Lymphocytes Reverses the Imbalance between Pro- and Anti-Tumor Immunities via Enhancing Antigen-Specific T Cell Immune Responses	Chen Y.-L.; Chang M.-C.; CHI-AN CHEN; Lin H.-W.; Cheng W.-F.; Chien C.-L.
臺大學術典藏	2020-01-22T07:50:36Z	Interferon-gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma	Chen Y.-L.;Cheng W.-F.;Chang M.-C.;Lin H.-W.;Huang C.-T.;Chien C.-L.;Chi-An Chen; Chen Y.-L.; Cheng W.-F.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Chien C.-L.; CHI-AN CHEN
臺大學術典藏	2020-01-22T07:50:30Z	Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma	Chiang Y.-C.;Lin H.-W.;Chang C.-F.;Chang M.-C.;Fu C.-F.;Chen T.-C.;Hsieh S.-F.;Chi-An Chen;Cheng W.-F.; Chiang Y.-C.; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; CHI-AN CHEN; Cheng W.-F.
臺大學術典藏	2020-01-22T07:50:29Z	IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients	Huang C.-T.; Hsieh S.-F.; CHI-AN CHEN; Cheng W.-F.; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.
臺大學術典藏	2020-01-22T07:50:24Z	Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation	Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; CHI-AN CHEN; Sun W.-Z.; Cheng W.-F.; Chen Y.-L.;Chang M.-C.;Chiang Y.-C.;Lin H.-W.;Sun N.-Y.;Chi-An Chen;Sun W.-Z.;Cheng W.-F.; Chen Y.-L.; Chang M.-C.
臺大學術典藏	2020-01-22T07:50:23Z	CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells	Lin H.-W.;Chiang Y.-C.;Sun N.-Y.;Chen Y.-L.;Chang C.-F.;Tai Y.-J.;Chi-An Chen;Cheng W.-F.; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; CHI-AN CHEN; Cheng W.-F.
臺大學術典藏	2020-01-22T07:50:23Z	CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer	Lin H.-W.;Fu C.-F.;Chang M.-C.;Lu T.-P.;Lin H.-P.;Chiang Y.-C.;Chi-An Chen;Cheng W.-F.; Lin H.-W.; Fu C.-F.; Chang M.-C.; Lu T.-P.; Lin H.-P.; Chiang Y.-C.; CHI-AN CHEN; Cheng W.-F.
臺大學術典藏	2020-01-22T07:50:22Z	mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment	Chen Y.-L.;Lin H.-W.;Sun N.-Y.;Yie J.-C.;Hung H.-C.;Chi-An Chen;Sun W.-Z.;Cheng W.-F.; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; CHI-AN CHEN; Sun W.-Z.; Cheng W.-F.
臺大學術典藏	2020-01-22T07:50:22Z	Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes	Sun N.-Y.;Chen Y.-L.;Lin H.-W.;Chiang Y.-C.;Chang C.-F.;Tai Y.-J.;Chi-An Chen;Sun W.-Z.;Chien C.-L.;Cheng W.-F.; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; CHI-AN CHEN; Sun W.-Z.; Chien C.-L.; Cheng W.-F.
臺大學術典藏	2020-01-22T07:50:20Z	BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes	Chen Y.-L.;Lin H.-W.;Chien C.-L.;Lai Y.-L.;Sun W.-Z.;Chi-An Chen;Cheng W.-F.; Chen Y.-L.; Lin H.-W.; Chien C.-L.; Lai Y.-L.; Sun W.-Z.; CHI-AN CHEN; Cheng W.-F.

顯示項目 141-165 / 342 (共14頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52880833 線上人數 : 678 教育部委託研究計畫計畫執行:國立臺灣大學圖書館